MeSH tree: C04.557.470.200
When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must determine whether the cause is cancer or a benign condition. The location of these ...
Mar 27, 2026
0
6
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference (EBCC15) in Barcelona.
Mar 26, 2026
0
6
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, ...
Mar 26, 2026
0
4
Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon cancer combined. When lung adenocarcinoma, the most common primary lung cancer in the U.S., grows into ...
Mar 24, 2026
0
6
A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the HKU State Key Laboratory of Liver Research, has found ...
Mar 24, 2026
0
7
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment. Small cell neuroendocrine cancers, aggressive ...
Mar 23, 2026
0
45
Cancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different genetic paths. A new study shows that these differences can sometimes be traced back to tiny changes in ...
Mar 22, 2026
0
18
A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to conventional treatments. ...
Mar 18, 2026
0
5
Liver cancer in children is rare, but when it occurs, the two main types are hepatoblastoma (HB) and hepatocellular carcinoma (HCC). In some cases, however, the tumors show features of both types. These tumors have been classified ...
Mar 16, 2026
0
7
New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy ...
Mar 15, 2026
0
4
